First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial - Concepedia

Concepedia

Publication | Open Access

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial

DOI Full Paper Access

118

Citations

29

References

2020

Year

M Jongsma, M Aardoom, Martinus A. Cozijnsen, Merel van Pieterson, Tim de Meij, Michael Groeneweg, Obbe F. Norbruis, Victorien M. Wolters, Herbert M. van Wering, Iva Hojsak,

Abstract

ClinicalTrials.gov Registry (NCT02517684).

References

	Year	Citations

Page 1